Novonesis A S ADR (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 650,576 | 616,104 | 666,174 | 622,605 | 590,855 |
| Cost of Goods | 300,468 | 274,814 | 305,492 | 290,375 | 273,171 |
| Gross Profit | 350,108 | 341,290 | 360,682 | 332,230 | 317,684 |
| Operating Expenses | 201,364 | 215,727 | 197,765 | 191,842 | 143,724 |
| Operating Income | 149,212 | 126,377 | 163,409 | 140,763 | 174,131 |
| Interest Expense | 0 | 9,935 | 12,825 | 56,665 | 0 |
| Other Income | 18,396 | 146 | -721 | 61,253 | 13,665 |
| Pre-tax Income | 167,608 | 116,588 | 149,864 | 145,351 | 187,796 |
| Income Tax | 31,974 | 26,882 | 34,440 | 22,767 | 31,796 |
| Net Income Continuous | 135,634 | 89,705 | 115,424 | 122,584 | 156,001 |
| Minority Interests | -1,022 | 1,169 | 2,450 | -919 | 135 |
| Net Income | $136,656 | $88,537 | $112,974 | $123,503 | $155,866 |
| EPS Basic Total Ops | 0.49 | 0.32 | 0.41 | 0.45 | 0.56 |
| EPS Basic Continuous Ops | 0.49 | 0.32 | 0.42 | 0.44 | 0.56 |
| EPS Diluted Total Ops | 0.49 | 0.32 | 0.41 | 0.44 | 0.56 |
| EPS Diluted Continuous Ops | 0.49 | 0.32 | 0.42 | 0.44 | 0.56 |
| EPS Diluted Before Non-Recurring Items | 0.49 | 0.32 | 0.41 | 0.44 | N/A |
| EBITDA(a) | $149,212 | $126,377 | $163,409 | $140,763 | $174,131 |